CLRPF
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals Ltd. (CLRPF)
$19
About CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals Ltd. (CLRPF)
Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$6.40
52 Week Low
$0.84
Market cap
380.8M
Dividend yield
0.00%
Volume
--
Avg. volume
13,761
P/E ratio
-10.98
CLARITY PHARMACEUTICALS by Clarity Pharmaceuticals Ltd. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$6.40
52 Week Low
$0.84
Market cap
380.8M
Dividend yield
0.00%
Volume
--
Avg. volume
13,761
P/E ratio
-10.98